Jamiel E. Poindexter is a partner in the Tax Department and a member of the Private Funds Group. He focuses on tax and economic issues associated with the formation of and investments in U.S. and non-U.S. venture capital funds, buyout funds, funds-of-funds, secondary funds, and other investment partnerships.
Jamiel advises U.S. and non-U.S. sponsors and institutional investors on all types of fund-related transactions and operations, including:
investments by institutional investors in private investment funds;
buy-side secondary transactions and sell-side secondary transactions;
restructuring of existing funds;
spin outs;
succession planning; and
portfolio company investments.
Chambers USA: Massachusetts: Tax 2014-2021, 2023-2024
The Legal 500 United States: Taxes: Non-Contentious 2016-2017, 2023-2024
Massachusetts Super Lawyers "Rising Stars"
Massachusetts Super Lawyers "Super Lawyers"
Best Lawyers in America 2016-2025
Law Business Research’s Who’s Who Legal: Private Funds 2024
Aberdeen Asset Management: represent fund-of-funds manager in its fund formation and portfolio investments.
Alcatel-Lucent Asset Management Corporation: represent corporate pension plan in its alternative investments.
Arch Venture Partners: represent U.S.-based venture capital fund manager in its fund formation and investment activities.
California State Teachers Retirement System: represent second largest U.S. public pension plan in its alternative investments.
General Catalyst Partners: represent U.S.-based venture capital fund manager in its fund formations.
HQ Capital: represent global fund-of-funds and secondary funds manager in its fund formations and its primary and secondary investments.
Lexington Partners: represent global fund manager in the formation of secondary funds, and in secondary, primary and co-investment transactions.
MIT Investment Management Company: represent university endowment in its alternative investments.
New Enterprise Associates: represent U.S.-based venture capital fund manager in its fund formations and portfolio investments.
NovaQuest Capital Management: Represent pharmaceutical fund manager in its fund formations.
W Capital Partners: represent “secondary direct” fund manager in its fund formations and its portfolio transactions.